Literature DB >> 8004590

Changing trends. An overview of breast cancer incidence and mortality.

L Garfinkel1, C C Boring, C W Heath.   

Abstract

The incidence of breast cancer rose about 1% per year between 1940 and 1980 according to data in the Connecticut Tumor Registry. A sharp increase of 32% was reported between 1980 and 1987 in the Surveillance, Epidemiology and End Results Program of the National Cancer Institute. Data from this program shows that the increase in incidence was due to localized cases and cancers of less than 2 cm in greatest dimension. In addition, a sharp increase in carcinoma in situ was observed. The increase in breast cancer incidence coincides with an increased use of mammography in asymptomatic women in the 1980s. Mortality from breast cancer has changed little since the 1930s, but the increases in localized and small-size tumors and decreases in the rate of tumors of 3 cm or larger at diagnosis indicates that breast cancer mortality may start to decrease. Evidence from provisional breast cancer monthly mortality data suggests that there was a 3-6% drop in 1991 compared to 1990.

Entities:  

Mesh:

Year:  1994        PMID: 8004590     DOI: 10.1002/cncr.2820741304

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  25 in total

1.  Declining mammography screening in a state Medicaid Fee-for-Service program: 1999-2008.

Authors:  Abhijeet Bhanegaonkar; S Suresh Madhavan; Rahul Khanna; Scot C Remick
Journal:  J Womens Health (Larchmt)       Date:  2012-05-08       Impact factor: 2.681

2.  Optical Fourier techniques for medical image processing and phase contrast imaging.

Authors:  Chandra S Yelleswarapu; Sri-Rajasekhar Kothapalli; D V G L N Rao
Journal:  Opt Commun       Date:  2008-04-01       Impact factor: 2.310

3.  Arguments against mammography screening continue to be based on faulty science.

Authors:  Daniel B Kopans
Journal:  Oncologist       Date:  2014-02

4.  Were our estimates of overdiagnosis with mammography screening in the United States "based on faulty science"?

Authors:  Archie Bleyer
Journal:  Oncologist       Date:  2014-02

5.  More misinformation on breast cancer screening.

Authors:  Daniel B Kopans
Journal:  Gland Surg       Date:  2017-02

Review 6.  Toremifene. A review of its pharmacological properties and clinical efficacy in the management of advanced breast cancer.

Authors:  L R Wiseman; K L Goa
Journal:  Drugs       Date:  1997-07       Impact factor: 9.546

7.  Relevance of the viral RAK alpha gene in diagnosis of malignant versus nonmalignant tumors of the ovary and uterus.

Authors:  E M Rakowicz-Szulczynska
Journal:  Clin Diagn Lab Immunol       Date:  2000-05

8.  HLA class-II allele frequencies in Turkish breast cancer patients.

Authors:  Faik Deniz Gun; Ozlem Goruroglu Ozturk; Ayse Polat; Gurbuz Polat
Journal:  Med Oncol       Date:  2011-03-04       Impact factor: 3.064

Review 9.  Screening for breast cancer in 2018-what should we be doing today?

Authors:  J M Seely; T Alhassan
Journal:  Curr Oncol       Date:  2018-06-13       Impact factor: 3.677

10.  Human immunodeficiency virus type 1-like DNA sequences and immunoreactive viral particles with unique association with breast cancer.

Authors:  E M Rakowicz-Szulczynska; B Jackson; A M Szulczynska; M Smith
Journal:  Clin Diagn Lab Immunol       Date:  1998-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.